Oncological outcomes of radical nephroureterectomy for upper urinary tract urothelial neoplasia in Denmark

References

• Peyronnet B, Seisen T, Dominguez-Escrig J-L, et al. Oncological outcomes of laparoscopic nephroureterectomy versus open radical nephroureterectomy for upper tract urothelial carcinoma: an European Association of Urology guidelines systematic review. Eur Urol Focus. 2019;5(2):205–223.
   PubMedGoogle Scholar
• Margulis V, Shariat SF, Matin SF, et al. Outcomes of radical nephroureterectomy: a series from the Upper Tract Urothelial Carcinoma Collaboration. Cancer. 2009;115(6):1224–1233.
   PubMed Web of Science ®Google Scholar
• Lynge E, Sandegaard JL, Rebolj M. The Danish national patient register. Scand J Public Health. 2011;39(7_suppl):30–33.
   PubMed Web of Science ®Google Scholar
• Rouprêt M, Babjuk M, Compérat E, et al. European Association of Urology guidelines on Upper Urinary Tract Urothelial Carcinoma: 2017 update. Eur Urol. 2018;73(1):111–122.
   PubMed Web of Science ®Google Scholar
• Wong MCS, Fung FDH, Leung C, et al. The global epidemiology of bladder cancer: a joinpoint regression analysis of its incidence and mortality trends and projection. Sci Rep. 2018;8(1):1129.
   PubMed Web of Science ®Google Scholar
• Nielsen ME, Smith AB, Meyer A-M, et al. Trends in stage-specific incidence rates for urothelial carcinoma of the bladder in the United States: 1988–2006. Cancer. 2014;120(1):86–95.
   PubMed Web of Science ®Google Scholar
• Jensen H, Tørring ML, Vedsted P. Prognostic consequences of implementing cancer patient pathways in Denmark: a comparative cohort study of symptomatic cancer patients in primary care. BMC Cancer. 2017;17(1):627.
   Google Scholar
• Jensen H, Vedsted P. Exploration of the possible effect on survival of lead-time associated with implementation of cancer patient pathways among symptomatic first-time cancer patients in Denmark. Cancer Epidemiol. 2017;49:195–201.
   PubMed Web of Science ®Google Scholar
• Jensen H, Tørring ML, Olesen F, et al. Diagnostic intervals before and after implementation of cancer patient pathways – a GP survey and registry based comparison of three cohorts of cancer patients. BMC Cancer. 2015;15(1):308.
   PubMedGoogle Scholar
• Jensen H, Tørring ML, Olesen F, et al. Cancer suspicion in general practice, urgent referral and time to diagnosis: a population-based GP survey and registry study. BMC Cancer. 2014;14(1):636.
   PubMed Web of Science ®Google Scholar
• Ingeman ML, Christensen MB, Bro F, et al. The Danish cancer pathway for patients with serious non-specific symptoms and signs of cancer-a cross-sectional study of patient characteristics and cancer probability. BMC Cancer. 2015;15(1):421.
   PubMedGoogle Scholar
• Kim HS, Ku JH, Jeong CW, et al. Laparoscopic radical nephroureterectomy is associated with worse survival outcomes than open radical nephroureterectomy in patients with locally advanced upper tract urothelial carcinoma. World J Urol. 2016;34(6):859–869.
   PubMed Web of Science ®Google Scholar
• Fairey AS, Kassouf W, Estey E, et al. Comparison of oncological outcomes for open and laparoscopic radical nephroureterectomy: results from the Canadian Upper Tract Collaboration. BJU Int. 2013;112(6):791–797.
   PubMed Web of Science ®Google Scholar
• Elawdy MM, Osman Y, Taha DE, et al. Risk factors and prognosis of intravesical recurrence after surgical management of upper tract urothelial carcinoma: a 30-year single centre experience. Arab J Urol. 2017;15(3):216–222.
   PubMed Web of Science ®Google Scholar
• Xylinas E, Rink M, Margulis V, et al. Multifocal carcinoma in situ of the upper tract is associated with high risk of bladder cancer recurrence. Eur Urol. 2012;61(5):1069–1070.
   PubMed Web of Science ®Google Scholar
• Huang Y, Wei J, Fang Y, et al. Prognostic value of AIB1 and EIF5A2 in intravesical recurrence after surgery for upper tract urothelial carcinoma. CMAR. 2018;10:6997–7011.
   Google Scholar
• Billerey C, Chopin D, Aubriot-Lorton MH, et al. Frequent FGFR3 mutations in papillary non-invasive bladder (pTa) tumors. Am J Pathol. 2001;158(6):1955–1959.
   PubMed Web of Science ®Google Scholar
• Ornitz DM, Itoh N. The Fibroblast Growth Factor signaling pathway. Wires Dev Biol. 2015;4(3):215–266.
   Web of Science ®Google Scholar
• Weyerer V, Schneckenpointner R, Filbeck T, et al. Immunohistochemical and molecular characterizations in urothelial carcinoma of bladder in patients less than 45 years. J Cancer. 2017;8(3):323–331.
   PubMed Web of Science ®Google Scholar
• Apollo A, Ortenzi V, Scatena C, et al. Molecular characterization of low grade and high grade bladder cancer. PloS One. 2019;14(1):e0210635.
   PubMed Web of Science ®Google Scholar
• Chung S-D, Chen S-C, Wang S-M, et al. Long-term outcome of hand-assisted laparoscopic nephroureterectomy for pathologic T3 upper urinary tract urothelial carcinoma. J Endourol. 2009;23(1):75–80.
   PubMed Web of Science ®Google Scholar
• Hemal AK, Kumar A, Gupta NP, et al. Retroperitoneal nephroureterectomy with excision of cuff of the bladder for upper urinary tract transitional cell carcinoma: comparison of laparoscopic and open surgery with long-term follow-up. World J Urol. 2008;26(4):381–386.
   PubMed Web of Science ®Google Scholar
• Kobayashi H, Kikuchi E, Tanaka N, et al. Patient age was an independent predictor of cancer-specific survival in male patients with upper tract urothelial carcinoma treated by radical nephroureterectomy. Jpn J Clin Oncol. 2016;46(6):554–559.
   PubMed Web of Science ®Google Scholar
• Freedman RA, Keating NL, Lin NU, et al. Breast cancer-specific survival by age: worse outcomes for the oldest patients. Cancer. 2018;124(10):2184–2191.
   PubMed Web of Science ®Google Scholar
• Skyrud KD, Bray F, Møller B. A comparison of relative and cause-specific survival by cancer site, age and time since diagnosis. Int J Cancer. 2014;135(1):196–203.
   PubMed Web of Science ®Google Scholar
• Cai M, Wei J, Zhang Z, et al. Impact of age on the cancer-specific survival of patients with localized renal cell carcinoma: martingale residual and competing risks analysis. PLoS One. 2012;7(10):e48489.
   PubMed Web of Science ®Google Scholar
• Fajkovic H, Cha EK, Xylinas E, et al. Disease-free survival as a surrogate for overall survival in upper tract urothelial carcinoma. World J Urol. 2013;31(1):5–11.
   PubMed Web of Science ®Google Scholar
• De Groote R, Decaestecker K, Larcher A, et al. Robot-assisted nephroureterectomy for upper tract urothelial carcinoma: results from three high-volume robotic surgery institutions. J Robot Surg. 2019. doi:10.1007/s11701-019-00965-8.
   Google Scholar
• Ariane MM, Colin P, Ouzzane A, et al. Assessment of oncologic control obtained after open versus laparoscopic nephroureterectomy for upper urinary tract urothelial carcinomas (UUT-UCs): results from a large French multicenter collaborative study. Ann Surg Oncol. 2012;19(1):301–308.
   PubMed Web of Science ®Google Scholar